Diethylstilbestrol (DES)-induced fetal thymic atrophy in C57BL/6 mice: Inhibited thymocyte differentiation and increased apoptotic cell death

International Journal of Toxicology

Volumn 24, Issue 4, 2005, Pages 231-239

  Besteman, Elizabeth G ^a   Zimmerman, Kurt L ^a   Holladay, Steven D ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

DES; Developmental; Immune; Murine; Thymus

Indexed keywords

7 AMINODACTINOMYCIN; CD4 ANTIGEN; CD8 ANTIGEN; DIETHYLSTILBESTROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; FEMALE; FETUS; FLOW CYTOMETRY; GESTATIONAL AGE; HISTOPATHOLOGY; HORMONE METABOLISM; MOUSE; NONHUMAN; PHENOTYPE; PREGNANCY COMPLICATION; RISK FACTOR; THYMUS ATROPHY;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; APOPTOSIS; ATROPHY; CELL DIFFERENTIATION; DIETHYLSTILBESTROL; FEMALE; FETUS; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; ORGAN SIZE; PREGNANCY; THYMUS GLAND;

MURINAE;

EID: 23744493794     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810591000703     Document Type: Article

References (32)

1. Ahmed, S. A. 2000. The immune system as a potential target for environmental estrogens (endocrine disrupters): A new emerging field. Toxicology 150:191-206.
2. Bamigboye, A. A., and J. Morris. 2003. Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes. Cochran Database of Syst. Rev. 3:CD004271.
3. Barnes, D. W., D. G. Page, S. S. Duke, and K. L. White. 1983. Subchronic toxicology of diethylstilbestrol in the mouse. Drug Chem. Toxicol. 6:455-485.
4. Burke, L., M. Segall-Blank, C. Lorenzo, R. Dynesius-Trentham, D. Trentham, and J. F. Mortola. 2001. Altered immune response in adult women exposed to diethylstilbestrol in utero. Am. J. Obstet. Gynecol. 185:78-81.
5. Calemine, J. B., R. M. Gogal Jr, A. Lengi, P. Sponenberg, and S. A. Ahmed. 2002. Immunomodulation by diethylstilbestrol is dose and gender related: Effects on thymocyte apoptosis and mitogen-induced proliferation. Toxicology 178:101-118.
6. Chodak, G. W., T. Keane, and L. Klotz. 2002. Critical evaluation of hormonal therapy for carcinoma of the prostate. Urology 60:201-208.
7. Do, Y., S. Ryu, M. Nagarkatti, and P. S. Nagarkatti. 2002. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol. Sci. 70:63-72.
8. Donner, K. J., K. M. Becker B. D. Hissong, and S. A. Ahmed. 1999. Comparison of multiple assays for kinetic detection of apoptosis in thymocytes exposed to dexamethasone or diethylstilbestrol. Cytometry 35:80-90.
9. Elgert, K. D. 1996. Cells and organs of the immune system, pp. 22-45. In Immunology, understanding the immune system. New York: Wiley-Liss.
10. Forsberg, J. G. 1996. The different responses of the female mouse thymus to estrogen after treatment of neonatal, prepubertal, and adult animals. Acta Anat. 157:275-290.
11. Gangemi, M., O. De Candia, and R. De Candia. 1995. Substitutive hormonal treatment in postmenopause. Clin. Exp. Obstet. Gynecol. 22:143-144.
12. Could, K. A., J. D. Shull, and J. Gorski. 2000. DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol. Cell. Endocrinol. 170:31-39.
13. Holladay, S. D., B. L. Blaylock, C. E. Comment, J. J. Heindel, W. M. Fox, K. S. Korach, and M. I. Luster. 1993. Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell. Immunol. 152:131-142.
14. Holladay, S. D., and R. J. Smialwicz. 2000. Development of the murine and human immune system: Differential effects of immunotoxicants depend on time of exposure. Environ. Health Perspect. 108(Suppl. 3):463-473.
15. Holsapple, M. P. , A. E. Munson, J. A. Munson, and P. H. Bick. 1983. Suppression of cell-mediated immunocompetence after subchronic exposure to diethylstilbestrol in female B6C3F1 mice. J. Exp. Ther. 227:130-138.
16. Jiang, D., L. Zheng, and M. J. Lenardo. 1999. Caspases in T-cell receptor-induced thymocyte apoptosis. Cell Death Differ. 6:402-411.
17. Kamath, A. B., H. Xu, P. S. Nagarkatti, and M. Nagarkatti. 1997. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicol. Appl. Pharmacol. 142:367-377.
18. Lai, Z. W., N. I. Fiore, P. J. Hahn, T. A. Gasiewicz, and A. E. Silverstone. 2000. Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol. Appl. Pharmacol. 168:15-24.
19. Luster, M. I., G. A. Boorman, K. S. Korach, M. P. Dieter, and L. Hong. 1984a. Mechanisms of estrogen-induced myelotoxicity: evidence of thymic regulation. Int. J. Immunophamacol. 6:287-297.
20. Luster, M. I., H. T. Hayes, K. Korach, A. N. Tucker, J. H. Dean, W. F. Greenlee, and G. A. Boorman. 1984b. Estrogen immunosuppression is regulated through estrogenic responses in the thymus. J. Immunol. 133:110-116.
21. McLachlan, J. A. 1979. Transplacental effects of diethylstilbestrol in mice. Natl. Cancer Inst. Monogr. 51:67-72.
22. Mor, G., A. Munoz, R. Redlinger Jr., I. Silva, J. Song, C. Lim, and F. Kohen. 2001. The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am. J. Reprod. Immunol. 46:298-307.
23. Nilsson, N., and H. Carlsten. 1994. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell. Immunol. 158:131-139.
24. Rijhsinghani, A., S. K. Bhatia, L. Kantamneni, A. Schlueter, and T. J. Waldschmidt. 1997. Estrogen inhibits fetal thymocyte development in vitro. Am. J. Reprod. Immunol. 37:384-390.
25. Seiki, K., and K. Sakabe. 1997. Sex hormones and the thymus in relation to thymocyte proliferation and maturation. Arch. Histol. Cytol. 60:29-38.
26. Shah, H. C., and J. A. McLachlan. 1976. The fate of diethylstilbestrol in the pregnant mouse. J. Pharmacol. Exp. Ther. 197:687-696.
27. Small, M., and G. Kraal. 2003. In vitro evidence for participation of DEC-205 expressed by thymic cortical epithelial cells in clearance of apoptotic thymocytes. Int. Immunol. 15:197-203.
28. Silverstone, A. E., D. E. Frazier, N. C. Fiore, J. A. Soults, and T. A. Gasiewicz. 1994. Dexamethasone, β-estradiol, and 2,3,7,8- tetrachlorodibenzo-p-dioxin elicit thymic atrophy though different cellular targets. Toxicol. Appl. Pharmacol. 126:248-259.
29. Staples, J. E., N. C. Fiore, D. E. Frazier, T. A. Gasiewicz, and A. E. Silverstone. 1998. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 151:200-210.
30. Vingerhoets, A. J., J. Assies, K. Goodkin, G. L. Van Heck, and M. H. Bekker. 1998. Prenatal diethylstilbestrol exposure and self-reported immune-related diseases. Eur. J. Obstet. Gynecol. Reprod. Biol. 77:205-209.
31. Yao, G., and Y. Hou. 2004. Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway. Int. Immunopharmacol. 4:213-221.
32. Zajchowski, S., and L. Hoffman-Goetz. 2000. Supraphysiological level of estrogen exposure in vivo increases lymphoid cell death in mice. Life. Sci. 66:1451-1459.